The Prophylactic Effect of Dexmedetomidine 0.008% Versus Brimonidine 0.2% on IOP Elevation After Nd: YAG Laser Capsulotomy.

Pharmacol Res Perspect · 2026 · PMC13239948 · PMID 42192576

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

marginally significantp = 0.09so close (0.05 < p ≤ 0.1)

Additionally, the incidence of IOP exceeding 30 mmHg at 4 h was marginally significant and higher in the dexmedetomidine group (7%) compared with the brimonidine group (2%) ( p = 0.09). 3.1 Adverse Events No ocular adverse events, such as hyperemia, were observed in either group.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.